These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 560216)

  • 41. Catalysis of the generation of thrombin-antithrombin complex by insoluble anticoagulant polystyrene derivatives.
    Fougnot C; Jozefowicz M; Rosenberg RD
    Biomaterials; 1984 Mar; 5(2):94-9. PubMed ID: 6722255
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of rabbit thrombomodulin on the inhibition of thrombin by the antithrombin-heparin complex: role of the acid domain of thrombomodulin].
    Bourin MC
    C R Acad Sci III; 1987; 304(8):173-6. PubMed ID: 3028582
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
    Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J
    J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decreased heparin sensitivity of cycholhexanedione-modified thrombin.
    Machovich R; Staub M; Patthy L
    Eur J Biochem; 1978 Feb; 83(2):473-7. PubMed ID: 631129
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The heparin-accelerated neutralisation of bovine alpha and beta thrombins by antithrombin III.
    MacGregor IR; Lane DA; Kakkar VV
    Biochim Biophys Acta; 1980 Sep; 632(1):131-7. PubMed ID: 7417517
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The interaction of heparin with thrombin and antithrombin.
    Rosenberg RD; Oosta GM; Jordan RE; Gardner WT
    Biochem Biophys Res Commun; 1980 Oct; 96(3):1200-8. PubMed ID: 7437065
    [No Abstract]   [Full Text] [Related]  

  • 47. A disulfide bond in antithrombin is required for heparin-accelerated thrombin inactivation.
    Longas MO; Ferguson WS; Finlay TH
    J Biol Chem; 1980 Apr; 255(8):3436-41. PubMed ID: 7364749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin.
    Bray B; Lane DA; Freyssinet JM; Pejler G; Lindahl U
    Biochem J; 1989 Aug; 262(1):225-32. PubMed ID: 2818566
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kinetics of the heparin-enhanced antithrombin III/thrombin reaction. Evidence for a template model for the mechanism of action of heparin.
    Griffith MJ
    J Biol Chem; 1982 Jul; 257(13):7360-5. PubMed ID: 7085630
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of heparin on thrombin inactivation by antithrombin-III.
    Machovich R; Arányi P
    Biochem J; 1978 Sep; 173(3):869-75. PubMed ID: 708377
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of a new laboratory test to evaluate antithrombin resistance in plasma.
    Murata M; Takagi A; Suzuki A; Okuyama E; Takagi Y; Ando Y; Kato I; Nakamura Y; Murate T; Matsushita T; Saito H; Kojima T
    Thromb Res; 2014 Feb; 133(2):293-8. PubMed ID: 24325876
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activity toward thrombin-antithrombin of heparin immobilized on two hydrogels.
    Tay SW; Merrill EW; Salzman EW; Lindon J
    Biomaterials; 1989 Jan; 10(1):11-5. PubMed ID: 2713428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inactivation of alpha- and beta-thrombin by antithrombin-III, alpha 2-macroglobulin and alpha 1-proteinase inhibitor.
    Machovich R; Borsodi A; Blaskó G; Orakzai SA
    Biochem J; 1977 Nov; 167(2):393-8. PubMed ID: 74248
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of tryptophan residues in heparin-antithrombin interactions.
    Karp GI; Marcum JA; Rosenberg RD
    Arch Biochem Biophys; 1984 Sep; 233(2):712-20. PubMed ID: 6486808
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
    Scully MF; Ellis V; Seno N; Kakkar VV
    Biochem J; 1988 Sep; 254(2):547-51. PubMed ID: 2902851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tryptophan 60-D in the B-insertion loop of thrombin modulates the thrombin-antithrombin reaction.
    Rezaie AR
    Biochemistry; 1996 Feb; 35(6):1918-24. PubMed ID: 8639675
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heparin-catalyzed inhibitor/protease reactions: kinetic evidence for a common mechanism of action of heparin.
    Griffith MJ
    Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5460-4. PubMed ID: 6577437
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interaction of thrombin and antithrombin. Reaction observed by intrinsic fluorescence measurements.
    Wong RF; Windwer SR; Feinman RD
    Biochemistry; 1983 Aug; 22(17):3994-9. PubMed ID: 6615813
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of a synthetic thrombin-inhibitor MD805 on the reaction between thrombin and plasma antithrombin-III.
    Hijikata-Okunomiya A; Okamoto S; Wanaka K
    Thromb Res; 1990 Sep; 59(6):967-77. PubMed ID: 2264021
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Anticoagulating activity and lytic action of the heparin-antithrombin III and antithrombin III-heparin-thrombin complexes on non-stabilized fibrin].
    Kudriashov BA; Pastorova VE; Liapina LA
    Biokhimiia; 1981 Nov; 46(11):2024-9. PubMed ID: 7317530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.